PRAX Investors Have Opportunity to Join Praxis Precision Medicines, Inc. Fraud Investigation with the Schall Law Firm

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors ofPraxis Precision Medicines, Inc. (“Praxis” or “the Company”) (NASDAQ: PRAX) for violations of the securities laws. https://mma.prnewswire.com/media/1396534/Schall_Firm_Logo.jpg The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent […]

AIN Investors Have Opportunity to Join Albany International Corp. Fraud Investigation with the Schall Law Firm

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors ofAlbany International Corp. (“Albany” or “the Company”) (NYSE: AIN) for violations of the securities laws. https://mma.prnewswire.com/media/1396534/Schall_Firm_Logo.jpg The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to

SpotOn GPS Fence Earns Dual Honors: Named to 2025 Inc. 5000 List and Winners of the Pet Innovation Award

Manchester, New Hampshire, Aug. 14, 2025 (GLOBE NEWSWIRE) — SpotOn GPS Fence, the leading GPS-based dog containment system, has been recognized with two prestigious honors this year, earning a place on the 2025 Inc. 5000 list of America's fastest-growing private companies and winning the 2025 Pet Innovation Award for Fencing Product of the Year. The

SpotOn GPS Fence Earns Dual Honors: Named to 2025 Inc. 5000 List and Winners of the Pet Innovation Award

SpotOn GPS Fence Earns Dual Honors: Named to 2025 Inc. 5000 List and Winners of the Pet Innovation Award As a multi-year recipient of both honors, SpotOn's continued recognition reflects its commitment to innovation, customer service, and product R&D. GlobeNewswire August 14, 2025 Manchester, New Hampshire, Aug. 14, 2025 (GLOBE NEWSWIRE) — SpotOn GPS Fence,

SuperCom Reports Record Net Income of $5.3 Million and Non-GAAP EPS of $1.84 for First Half 2025

Q2: Revenue of $7.14 Million; Net Income of $1.1 Million; non-GAAP EPS of $0.49 ; EBITDA of $2.5 Million H1: Revenue of $14.2 Million; Gross Margin of 61.2%; Non-GAAP Net Income of $7.4 Million SuperCom (NASDAQ: SPCB),a global provider of secured solutions for the e-Government, IoT, and Cybersecurity sectors, today reported results for the second

SIKH PRAYER FOR MAGA: “LONG LIVE TRUMP – LONG LIVE AMERICA” TO MARK AUGUST 17 KHALISTAN REFERENDUM IN WASHINGTON, D.C., ANNOUNCES SIKHS FOR JUSTICE

On August 17,Pro-Khalistan Sikhs will gather at the historic National Mall to perform a special Ardas (Sikh prayer) for President Trump and the United States of America. With the resounding call “Long Live Trump – Long Live America”, the event will coincide with the U.S. voting phase of the Khalistan Referendum – a global democratic

KLC Investors Have Opportunity to Lead KinderCare Learning Companies, Inc. Securities Fraud Lawsuit with the Schall Law Firm

The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit againstKinderCare Learning Companies, Inc. (“KinderCare” or “the Company”) (NYSE: KLC)for violations of the federal securities laws. https://mma.prnewswire.com/media/1396534/Schall_Firm_Logo.jpg Investors who purchased the Company's securities pursuant and/or traceable to the Company's Offering Documents issued in connection with its initial

D. Boral Capital Acted as Exclusive Placement Agent to WEBUY GLOBAL LTD. (Nasdaq: WBUY) in Connection with its $3,000,000 Follow-on Offering

NEW YORK CITY, NEW YORK / ACCESS Newswire / August 14, 2025 / On August 1, 2025, WEBUY GLOBAL LTD. (Nasdaq:WBUY) ("Webuy" or the "Company"), a technology-driven company transforming community e-commerce and travel across Southeast Asia, closed its offering of 721,918 Class A ordinary shares and pre-funded warrants to purchase up to 100,000 Class A

Lexaria’s Phase 1b GLP-1 Study Achieves Important “Last Patient Last Visit” Milestone

KELOWNA, BC / ACCESS Newswire / August 14, 2025 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, is pleased to announce that its Contract Research Organization ("CRO") has completed the important study milestone known as last patent last visit ("LPLV") in Lexaria’s Phase 1b glucagon-like peptide-1 ("GLP-1")

Scroll to Top